Adalimumab

Uses

Adalimumab is used in the treatment of ulcerative colitis, Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis.

How it Works

How Adalimumab works Adalimumab inhibits the action of specific chemical messengers that contribute to inflammation, swelling, and redness associated with certain joint diseases.

Side Effects

Common side effects of Adalimumab include sinus inflammation, upper respiratory tract infection, injection site reactions (such as pain, swelling, and redness), and infections.

Expert Advice

Administered by injection under the skin (subcutaneous).
Follow the dosage and duration recommended by your doctor.
Notify your doctor immediately if you experience:

Severe rash
Hives
Swelling of hands or face
Shortness of breath

Store the pen in the refrigerator.
If refrigeration is not possible, the pen can be kept at room temperature (below 30°C) for up to 2 weeks.
Do not freeze the pen.
Do not discontinue the medication abruptly without consulting your doctor first.

Other Combinations

Frequently asked questions

What type of drug is Adalimumab?

Adalimumab is a TNF blocker that reduces joint damage by decreasing swelling and improving joint function.

Can Adalimumab weaken your immune system?

Adalimumab can lower your immune system's ability to fight infections. Inform your doctor if you have any ongoing infections before starting this medication.

Should Adalimumab be stopped before any surgery?

Yes, Adalimumab should be discontinued before surgery and can be resumed afterward as advised by your surgeon and rheumatologist, typically once the wound has healed and there are no signs of infection.

Can Adalimumab be used with other arthritis medications?

Adalimumab can be combined with medications like methotrexate, prednisolone, naproxen, ibuprofen, and paracetamol, but not with other bDMARDs. Consult your doctor for specific recommendations.

What benefits can you expect from treatment with Adalimumab?

You may experience reduced joint swelling, pain, and stiffness, typically within the first 8 weeks of treatment.

;